“…An increased risk of several non-haematological cancers has been reported for GD patients. The increased risk of (Pinkhas et al, 1965;Benjamin et al, 1979;Ruestow et al, 1980;Garfinkel et al, 1982;Kolodny et al, 1982;Lee, 1982;Miller et al, 1982;Shoenfeld et al, 1982;Gal et al, 1988;Shiran et al, 1993;Shvidel et al, 1995;Allen et al, 1997;Brady et al, 1997;Harder et al, 2000;Mateja et al, 2000;Zimran et al, 2005;de Fost et al, 2006de Fost et al, , 2008Cheung et al, 2007;Grosbois et al, 2009;Machaczka et al, 2009;Taddei et al, 2009;Aubourg et al, 2011;Hawkesford et al, 2011;Lieblich et al, 2011); current report Amyloidosis (Dikman et al, 1978;Hanash et al, 1978;Hrebicek et al, 1996;Kaloterakis et al, 1999; N, number of patients, no conclusions on incidence of the reported malignancies can be drawn based on these data. One study (Lo et al, 2010) was excluded because it covered the same cohort reported by Taddei et al (2009 (2006), who reported two cases of HCC, resulting in a relative risk of 141Á3.…”